Technology-based Company.

Engaged in advancing innovative solutions for large-scale market applications

Medigus Filed a $3 Million Buyback Program

Tel Aviv, Israel, Dec. 01, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced it had filed a motion seeking a court approval for a capital reduction of up to $3 million for the Company’s buyback program, increasing the contemplated program from $2 million to $3 million.

Contingent upon court’s approval the buyback program will initiate during the first quarter of 2022.